Literature DB >> 8858522

Polyamine metabolism in gliomas.

R I Ernestus1, G Röhn, R Schröder, T Els, J Y Lee, N Klug, W Paschen.   

Abstract

Biosynthesis of the polyamines putrescine, spermidine, and spermine has been found to be activated in tissues with cellular proliferation. In the present study we have investigated polyamine levels and the activity of the first rate-limiting enzyme ornithine decarboxylase (ODC) in tumour samples obtained during operation of 202 patients with gliomas. Biochemical data were closely related to the grading of malignancy and to the morphological characteristics of each sample. Mean ODC activity was significantly higher in all gliomas as compared to peritumoural non-neoplastic brain. Furthermore, it was significantly higher (p < or = 0.001) in anaplastic gliomas who grade III and IV (9.0 +/- 9.6 nmol/g/h) than in gliomas WHO grade I and II (3.3 +/- 4.2 nmol/g/h). Highest enzyme activity (58.5 nmol/g/h) was found in solid and vital parts of malignant tumours, whereas predominantly necrotic areas exhibited low ODC activity (< 1 nmol/g/h). Thus, intra- and interindividual variability of ODC activity corresponded well to histomorphological heterogeneity in high-grade gliomas. Putrescine levels also increased with rising grade of malignancy, whereas spermidine and spermine levels did not correlate with the histological grading. In conclusion, high ODC activity represents a biochemical marker of malignancy in gliomas, but low values do not prove benignity. The present study reinforces the need of further and more extensive tumour sampling closely related to follow-up investigations in the heterogeneous group of gliomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858522     DOI: 10.1007/bf00182140

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  44 in total

1.  THE DETERMINATION AND DISTRIBUTION OF POLYAMINES IN MAMMALIAN NERVOUS SYSTEM.

Authors:  H SHIMIZU; Y KAKIMOTO; I SANO
Journal:  J Pharmacol Exp Ther       Date:  1964-02       Impact factor: 4.030

2.  Polyamine metabolism and function in brain.

Authors:  N Seiler
Journal:  Neurochem Int       Date:  1981       Impact factor: 3.921

3.  Activity of ornithine decarboxylase (ODC) and polyamine levels as biochemical markers of malignancy in human brain tumors.

Authors:  R I Ernestus; G Röhn; R Schröder; N Klug; K A Hossmann; W Paschen
Journal:  Acta Histochem Suppl       Date:  1992

Review 4.  Polyamines in rapid growth and cancer.

Authors:  J Jänne; H Pösö; A Raina
Journal:  Biochim Biophys Acta       Date:  1978-04-06

5.  The 5'- and 3'-untranslated regions of ornithine decarboxylase mRNA affect the translational efficiency.

Authors:  A Grens; I E Scheffler
Journal:  J Biol Chem       Date:  1990-07-15       Impact factor: 5.157

6.  Regional heterogeneity in the proliferative activity of human gliomas as measured by the Ki-67 labeling index.

Authors:  S W Coons; P C Johnson
Journal:  J Neuropathol Exp Neurol       Date:  1993-11       Impact factor: 3.685

7.  Effect of trimethyltin on ornithine decarboxylase in various regions of the mouse brain.

Authors:  S F Ali; G D Newport; W Slikker; S C Bondy
Journal:  Toxicol Lett       Date:  1987-03       Impact factor: 4.372

Review 8.  Polyamine metabolism and function.

Authors:  A E Pegg; P P McCann
Journal:  Am J Physiol       Date:  1982-11

9.  Immunohistochemical localization of L-ornithine decarboxylase in developing rat brain.

Authors:  A Dorn; M Müller; H G Bernstein; A Pajunen; M Järvinen
Journal:  Int J Dev Neurosci       Date:  1987       Impact factor: 2.457

10.  Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.

Authors:  D Stavrou; K Bise; J Groeneveld; U Stocker; H A Kretzschmar; E Keiditsch; P Mehraein
Journal:  Anticancer Res       Date:  1989 Nov-Dec       Impact factor: 2.480

View more
  8 in total

1.  CNS Anticancer Drug Discovery and Development Conference White Paper.

Authors:  Victor A Levin; Peter J Tonge; James M Gallo; Marc R Birtwistle; Arvin C Dar; Antonio Iavarone; Patrick J Paddison; Timothy P Heffron; William F Elmquist; Jean E Lachowicz; Ted W Johnson; Forest M White; Joohee Sul; Quentin R Smith; Wang Shen; Jann N Sarkaria; Ramakrishna Samala; Patrick Y Wen; Donald A Berry; Russell C Petter
Journal:  Neuro Oncol       Date:  2015-11       Impact factor: 12.300

2.  Polyamine metabolism in brain tumours: diagnostic relevance of quantitative biochemistry.

Authors:  R I Ernestus; G Röhn; R Schröder; T Els; W Paschen; N Klug
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-07       Impact factor: 10.154

3.  MicroRNA-27a distinguishes glioblastoma multiforme from diffuse and anaplastic astrocytomas and has prognostic value.

Authors:  Mónica Rivera-Díaz; Miguel A Miranda-Román; Daniel Soto; Mario Quintero-Aguilo; Humberto Ortiz-Zuazaga; María J Marcos-Martinez; Pablo E Vivas-Mejía
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

4.  Tissue-based assay for ornithine decarboxylase to identify patients likely to respond to difluoromethylornithine.

Authors:  Victor A Levin; Jacob L Jochec; Lisa M Shantz; Patricia E Koch; Anthony E Pegg
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

5.  ODC mRNA as a prognostic factor for predicting recurrence in meningiomas.

Authors:  A Klekner; A G Röhn; G Schillinger; R Schröder; N Klug; R I Ernestus
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

6.  Multiplatform Metabolomics Studies of Human Cancers With NMR and Mass Spectrometry Imaging.

Authors:  Anya B Zhong; Isabella H Muti; Stephen J Eyles; Richard W Vachet; Kristen N Sikora; Cedric E Bobst; David Calligaris; Sylwia A Stopka; Jeffery N Agar; Chin-Lee Wu; Mari A Mino-Kenudson; Nathalie Y R Agar; David C Christiani; Igor A Kaltashov; Leo L Cheng
Journal:  Front Mol Biosci       Date:  2022-04-08

Review 7.  11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas.

Authors:  Tarun Singhal; Tanjore K Narayanan; Viney Jain; Jogeshwar Mukherjee; Joseph Mantil
Journal:  Mol Imaging Biol       Date:  2007-10-24       Impact factor: 3.488

8.  Diagnostic impact of ornithine decarboxylase in meningiomas.

Authors:  Werner Stenzel; Gabriele Röhn; Hrvoje Miletic; Herbert Radner; Martina Deckert; Ralf-Ingo Ernestus
Journal:  J Neurooncol       Date:  2004-01       Impact factor: 4.130

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.